Investor

Investing in TruScreen is an opportunity to invest in the future health and wellbeing of women around the world.

Cervical cancer can and should be prevented.

TruScreen provides an accurate, real-time primary screening solution. 
Our screening solution is ideal for communities that can’t access conventional laboratory-based screening methods. It is affordable and easy to learn.

Our purpose is to ensure that all women of screening age – no matter who or where they are – have access to quality screening.

TruScreen manufactures and owns all rights to the TruScreen Cervical Cancer Screening System. The system comprises a medical device and AI-enabled process designed to detect, in real-time, the presence of pre-cancerous and cancerous tissue on the cervix.

TruScreen’s focus markets are countries where there is a lack of organised cervical cancer screening and the required infrastructure.